BANK OF AMERICA CORP /DE/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$529,440,660
+5.0%
5,197,729
+4.1%
0.06%
+9.4%
Q2 2023$504,043,914
-28.0%
4,994,985
-34.3%
0.05%
-26.4%
Q1 2023$699,630,677
+21.1%
7,604,681
+19.4%
0.07%
+9.1%
Q4 2022$577,830,008
+5.3%
6,369,378
-11.7%
0.07%0.0%
Q3 2022$548,577,000
-12.6%
7,217,174
-2.8%
0.07%
-7.0%
Q2 2022$627,572,000
-9.1%
7,424,251
-5.6%
0.07%
+6.0%
Q1 2022$690,219,000
+1.3%
7,865,735
+1.0%
0.07%
+1.5%
Q4 2021$681,242,000
-9.6%
7,788,298
-15.5%
0.07%
-15.4%
Q3 2021$753,395,000
-8.3%
9,212,470
+2.3%
0.08%
-8.2%
Q2 2021$821,311,000
+4.6%
9,001,642
-2.0%
0.08%
-3.4%
Q1 2021$785,478,000
-15.2%
9,189,032
-6.3%
0.09%
-26.1%
Q4 2020$926,387,000
+31.5%
9,810,302
+21.1%
0.12%
+24.0%
Q3 2020$704,432,000
-4.5%
8,100,623
-4.1%
0.10%
-14.3%
Q2 2020$737,597,000
+3.4%
8,445,111
-2.3%
0.11%
-12.5%
Q1 2020$713,056,000
-19.6%
8,648,328
-7.7%
0.13%
+0.8%
Q4 2019$887,350,000
+21.4%
9,371,109
+11.4%
0.13%
+16.5%
Q3 2019$731,204,000
-12.6%
8,414,309
-8.2%
0.11%
-14.2%
Q2 2019$836,972,000
-3.8%
9,166,269
+1.3%
0.13%
-5.9%
Q1 2019$870,130,000
+12.0%
9,050,656
-0.0%
0.14%
-0.7%
Q4 2018$776,909,000
+24.6%
9,053,828
+25.1%
0.14%
+40.2%
Q3 2018$623,526,000
+22.3%
7,236,823
+7.2%
0.10%
+15.5%
Q2 2018$509,860,000
-6.6%
6,749,533
-0.1%
0.08%
-9.7%
Q1 2018$546,017,000
-5.6%
6,753,463
-2.0%
0.09%
-4.1%
Q4 2017$578,675,000
-22.9%
6,892,269
-21.2%
0.10%
-18.5%
Q3 2017$750,695,000
+30.9%
8,744,261
+27.3%
0.12%
+4.4%
Q2 2017$573,449,000
+5.4%
6,870,122
-6.3%
0.11%
+5.6%
Q1 2017$544,304,000
+9.6%
7,328,730
+7.5%
0.11%
+0.9%
Q4 2016$496,790,000
-0.6%
6,820,295
+7.7%
0.11%
-2.7%
Q3 2016$499,873,000
-0.9%
6,330,691
+3.5%
0.11%
-6.0%
Q2 2016$504,615,000
+19.0%
6,115,806
+4.4%
0.12%
+13.6%
Q1 2016$424,192,000
-11.5%
5,855,757
+5.1%
0.10%
-9.6%
Q4 2015$479,212,000
-7.7%
5,569,642
-1.4%
0.11%
-11.6%
Q3 2015$519,227,000
+127.9%
5,648,680
+143.8%
0.13%
+74.3%
Q2 2015$227,873,000
-1.2%
2,317,192
-0.9%
0.07%
-5.1%
Q1 2015$230,637,000
+9.0%
2,338,891
+2.4%
0.08%
+2.6%
Q4 2014$211,658,000
-4.3%
2,284,244
-2.8%
0.08%
+5.6%
Q3 2014$221,224,000
+6.5%
2,350,194
+2.4%
0.07%
+9.1%
Q2 2014$207,789,000
-5.4%
2,295,247
-11.2%
0.07%
-19.5%
Q1 2014$219,764,000
-2.3%
2,584,857
-7.7%
0.08%
+1.2%
Q4 2013$225,048,000
+2.5%
2,799,815
-2.2%
0.08%
-6.9%
Q3 2013$219,624,000
+4.1%
2,863,042
-4.1%
0.09%
-2.2%
Q2 2013$211,046,0002,984,6580.09%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders